Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC1 |
Variant | T417I |
Impact List | missense |
Protein Effect | no effect |
Gene Variant Descriptions | TSC1 T417I lies within the region of the Tsc1 protein that mediates interaction with WDR45B (UniProt.org). T417I demonstrates cellular localization, binding to Tsc2, and inhibition of S6 phosphorylation similar to wild-type Tsc1 in culture (PMID: 18397877). |
Associated Drug Resistance | |
Category Variants Paths |
TSC1 mutant TSC1 T417I |
Transcript | NM_000368.5 |
gDNA | chr9:g.132910584G>A |
cDNA | c.1250C>T |
Protein | p.T417I |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001406601.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_000368.5 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
XM_017015097 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
XM_005272211 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_001406606.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
XM_006717271 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
XM_006717271.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_001406592.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_001406593.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
XM_017015096.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
XM_017015097.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_000368 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_001406605.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
XM_017015096 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
XM_011518979.2 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
XM_005272211.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_001406607.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_001406596.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_001406594.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_000368.4 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
XM_011518979.3 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_001406602.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
XM_011518979 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
NM_001406595.1 | chr9:g.132910584G>A | c.1250C>T | p.T417I | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|